loadpatents
name:-0.045512914657593
name:-0.034497022628784
name:-0.014153003692627
Gagnon; Lyne Patent Filings

Gagnon; Lyne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gagnon; Lyne.The latest application filed is for "use of sodium 2-(3-pentylphenyl)acetate in the treatment of alstrom syndrome".

Company Profile
13.34.40
  • Gagnon; Lyne - Laval CA
  • Gagnon; Lyne - Quebec N/A CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
Grant 11,267,779 - Gagnon , et al. March 8, 2
2022-03-08
Use Of Sodium 2-(3-pentylphenyl)acetate In The Treatment Of Alstrom Syndrome
App 20220016060 - GAGNON; LYNE ;   et al.
2022-01-20
Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
Grant 11,185,521 - Gagnon , et al. November 30, 2
2021-11-30
Plasminogen Treatment Of Conditions Associated With Pai-1 Overexpression
App 20210330761 - GAGNON; LYNE ;   et al.
2021-10-28
Methods And Compositions For Preventing Or Minimizing Epithelial-mesenchymal Transition
App 20210128694 - LAURIN; PIERRE ;   et al.
2021-05-06
Substituted Aromatic Compounds And Pharmaceutical Compositions For Tissue Self-repair And Regeneration
App 20210085626 - GAGNON; Lyne ;   et al.
2021-03-25
Phenylketone carboxylate compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
Grant 10,925,846 - Gagnon , et al. February 23, 2
2021-02-23
Substituted Aromatic Compounds and Pharmaceutical Uses Thereof
App 20210002202 - ZACHARIE; Boulos ;   et al.
2021-01-07
Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
Grant 10,869,849 - Gagnon , et al. December 22, 2
2020-12-22
Substituted aromatic compounds and pharmaceutical uses thereof
Grant 10,815,183 - Zacharie , et al. October 27, 2
2020-10-27
Substituted Aromatic Compounds And Pharmaceutical Compositions For The Prevention And Treatment Of Osteoporosis
App 20200237693 - GAGNON; Lyne ;   et al.
2020-07-30
Substituted Aromatic Compounds And Related Method For The Treatment Of Fibrosis
App 20200172462 - ZACHARIE; Boulos ;   et al.
2020-06-04
Substituted Aromatic Compounds And Pharmaceutical Compositions For Tissue Self-repair And Regeneration
App 20200078324 - Gagnon; Lyne ;   et al.
2020-03-12
Substituted aromatic compounds and related method for the treatment of fibrosis
Grant 10,550,066 - Zacharie , et al. Fe
2020-02-04
Substituted Aromatic Compounds For The Treatment Of Pulmonary Fibrosis, Liver Fibrosis,skin Fibrosis And Cardiac Fibrosis
App 20200017432 - GAGNON; Lyne ;   et al.
2020-01-16
Substituted aromatic compounds for the treatment of pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
Grant 10,450,258 - Gagnon , et al. Oc
2019-10-22
Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration
Grant 10,391,073 - Gagnon , et al. A
2019-08-27
Phenylketone Carboxylate Compounds And Pharamceutical Compositions For The Prevention And Treatment Of Osteoporosis
App 20190038580 - GAGNON; Lyne ;   et al.
2019-02-07
Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
Grant 10,105,331 - Gagnon , et al. October 23, 2
2018-10-23
Substituted Aromatic Compounds and Related Method for the Treatment of Fibrosis
App 20180237374 - ZACHARIE; Boulos ;   et al.
2018-08-23
Substituted Aromatic Compounds And Pharmaceutical Compositions For The Prevention And Treatment Of Osteoporosis
App 20180228750 - GAGNON; Lyne ;   et al.
2018-08-16
Substituted aromatic compounds and related method for the treatment of fibrosis
Grant 10,023,518 - Zacharie , et al. July 17, 2
2018-07-17
Substituted Aromatic Compounds And Pharmaceutical Uses Thereof
App 20180162799 - ZACHARIE; Boulos ;   et al.
2018-06-14
Substituted Aromatic Compounds For The Treatment Of Pulmonary Fibrosis, Liver Fibrosis,skin Fibrosis And Cardiac Fibrosis
App 20180134649 - GAGNON; Lyne ;   et al.
2018-05-17
Substituted aromatic compounds and pharmaceutical uses thereof
Grant 9,938,221 - Zacharie , et al. April 10, 2
2018-04-10
Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
Grant 9,884,802 - Gagnon , et al. February 6, 2
2018-02-06
Substituted Aromatic Compounds And Pharmaceutical Compositions For Tissue Self-repair And Regeneration
App 20170312237 - GAGNON; Lyne ;   et al.
2017-11-02
Substituted Aromatic Compounds and Pharmaceutical Compositions For The Prevention And Treatment Of Diabetes
App 20170209399 - GAGNON; Lyne ;   et al.
2017-07-27
Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
Grant 9,682,054 - Penney , et al. June 20, 2
2017-06-20
Medium-chain length fatty acids and glycerides as nephroprotection agents
Grant 9,532,962 - Pichette , et al. January 3, 2
2017-01-03
Phenylketone carboxylate compounds and pharmaceutical uses thereof
Grant 9,475,750 - Zacharie , et al. October 25, 2
2016-10-25
Compounds and compositions for the treatment of cancer
Grant 9,439,882 - Gagnon , et al. September 13, 2
2016-09-13
Substituted Aromatic Compounds and Related Method for the Treatment of Fibrosis
App 20160039736 - ZACHARIE; Boulos ;   et al.
2016-02-11
Substituted Aromatic Compounds For The Treatment Of Pulmonary Fibrosis, Liver Fibrosis,skin Fibrosis And Cardiac Fibrosis
App 20160023983 - GAGNON; Lyne ;   et al.
2016-01-28
Compounds And Compositions For The Treatment Of Cancer
App 20150313856 - GAGNON; Lyne ;   et al.
2015-11-05
Compounds and compositions for the treatment of cancer
Grant 9,114,118 - Gagnon , et al. August 25, 2
2015-08-25
Substituted Aromatic Compounds And Pharmaceutical Uses Thereof
App 20150094372 - ZACHARIE; Boulos ;   et al.
2015-04-02
Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer
Grant 8,946,190 - Gagnon , et al. February 3, 2
2015-02-03
Substituted aromatic compounds and pharmaceutical uses thereof
Grant 8,927,765 - Zacharie , et al. January 6, 2
2015-01-06
Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof
Grant 8,637,574 - Zacharie , et al. January 28, 2
2014-01-28
Phenylketone Carboxylate Compounds and Pharmaceutical Uses Thereof
App 20130225681 - Zacharie; Boulos ;   et al.
2013-08-29
Compounds and Pharmaceutical Compositions for Uses in Diabetes
App 20130225683 - Gagnon; Lyne ;   et al.
2013-08-29
Compounds and Compositions for the Treatment of Cancer
App 20130217645 - Gagnon; Lyne ;   et al.
2013-08-22
Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
Grant 8,487,001 - Gagnon , et al. July 16, 2
2013-07-16
Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives
Grant 8,258,295 - Zacharie , et al. September 4, 2
2012-09-04
Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
App 20120095102 - Zacharie; Boulos ;   et al.
2012-04-19
Substituted Aromatic Compounds and Pharmaceutical Uses thereof
App 20120088784 - Zacharie; Boulos ;   et al.
2012-04-12
Medium-chain length fatty alcohols as stimulators of hematopoiesis
Grant 8,071,580 - Penney , et al. December 6, 2
2011-12-06
Medium-Chain Length Fatty Acids and Glycerides as Nephroprotection Agents
App 20100286269 - Pichette; Vincent ;   et al.
2010-11-11
Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
App 20100279959 - Gagnon; Lyne ;   et al.
2010-11-04
Medium-Chain Length Fatty Acids, Salts and Triglycerides in Combination with Gemcitabine for Treatment of Pancreatic Cancer
App 20100273731 - Gagnon; Lyne ;   et al.
2010-10-28
Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
Grant 7,745,488 - Gagnon , et al. June 29, 2
2010-06-29
Triazine Derivatives, Compositions Containing Such Derivatives, and Methods of Treatment of Cancer and Autoimmune Diseases Using Such Derivatives
App 20100129350 - Zacharie; Boulos ;   et al.
2010-05-27
Triazine dimers for the treatment of autoimmune diseases
Grant 7,683,061 - Penney , et al. March 23, 2
2010-03-23
Triazine compounds and compositions thereof for the treatment of cancers
App 20090075867 - Gagnon; Lyne ;   et al.
2009-03-19
2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use
App 20090068169 - Penney; Christopher ;   et al.
2009-03-12
Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides
App 20080090848 - Penney; Christopher ;   et al.
2008-04-17
Medium-Chain Length Fatty Alcohols as Stimulators of Hematopoiesis
App 20080051324 - Penney; Christopher ;   et al.
2008-02-28
Triazine dimers for the treatment of autoimmune diseases
App 20070149528 - Penney; Christopher ;   et al.
2007-06-28
Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
App 20060128800 - Penney; Christopher ;   et al.
2006-06-15
Method for the treatment of inflammation
App 20050101632 - Gagnon, Lyne ;   et al.
2005-05-12
Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
App 20040147599 - Gagnon, Lyne ;   et al.
2004-07-29
Substituted purinyl derivatives with immunomodulating activity
Grant 5,994,361 - Penney , et al. November 30, 1
1999-11-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed